Operating Expenses Summary of Biotage AB (publ)

Biotage AB (publ)'s latest annual operating expenses in 2023 was 637 Million SEK , up 27.29% from previous year.
Biotage AB (publ)'s latest quarterly operating expenses in 2024 Q1 was 227 Million SEK , down -5.81% from previous quarter.
Biotage AB (publ) reported a annual operating expenses of 656 Million SEK in annual operating expenses 2022, up 31.46% from previous year.
Biotage AB (publ) reported a annual operating expenses of 499 Million SEK in annual operating expenses 2021, up 3.98% from previous year.
Biotage AB (publ) reported a quarterly operating expenses of 240 Million SEK for 2024 Q2, up 5.73% from previous quarter.
Biotage AB (publ) reported a quarterly operating expenses of 227 Million SEK for 2024 Q1, down -5.81% from previous quarter.

Annual Operating Expenses Chart of Biotage AB (publ) (2023 - 2002)

Historical Annual Operating Expenses of Biotage AB (publ) (2023 - 2002)

Year	Operating Expenses	Operating Expenses Growth
2023	637 Million SEK	27.29%
2022	656 Million SEK	31.46%
2021	499 Million SEK	3.98%
2020	479.89 Million SEK	0.04%
2019	479.69 Million SEK	20.28%
2018	398.82 Million SEK	20.37%
2017	331.34 Million SEK	12.77%
2016	293.83 Million SEK	8.83%
2015	269.98 Million SEK	20.34%
2014	224.35 Million SEK	6.64%
2013	210.38 Million SEK	-6.86%
2012	225.88 Million SEK	2.12%
2011	221.2 Million SEK	-4.06%
2010	230.56 Million SEK	-1.98%
2009	235.22 Million SEK	16.47%
2008	201.96 Million SEK	-22.63%
2007	261.02 Million SEK	-13.59%
2006	302.07 Million SEK	5.78%
2005	285.58 Million SEK	2.39%
2004	278.92 Million SEK	10.2%
2003	253.11 Million SEK	10.53%
2002	229 Million SEK	0.0%

Year	Operating Expenses	Operating Expenses Growth
2024 Q3	238 Million SEK	-0.83%
2024 Q2	240 Million SEK	5.73%
2024 Q1	227 Million SEK	-5.81%
2023 Q1	166 Million SEK	-24.55%
2023 FY	637 Million SEK	-2.9%
2023 Q3	217 Million SEK	7.96%
2023 Q2	201 Million SEK	21.08%
2023 Q4	241 Million SEK	11.06%
2022 Q3	144 Million SEK	-2.04%
2022 FY	656 Million SEK	31.46%
2022 Q1	145 Million SEK	-12.65%
2022 Q2	147 Million SEK	1.38%
2022 Q4	220 Million SEK	52.78%
2021 FY	499 Million SEK	3.98%
2021 Q1	98.08 Million SEK	-29.13%
2021 Q2	119.66 Million SEK	22.0%
2021 Q4	166 Million SEK	44.35%
2021 Q3	115 Million SEK	-3.9%
2020 Q1	112.02 Million SEK	-21.9%
2020 FY	479.89 Million SEK	0.04%
2020 Q4	138.39 Million SEK	38.6%
2020 Q3	99.85 Million SEK	-22.97%
2020 Q2	129.62 Million SEK	15.72%
2019 FY	479.69 Million SEK	20.28%
2019 Q3	113.3 Million SEK	-5.42%
2019 Q2	119.79 Million SEK	16.12%
2019 Q1	103.16 Million SEK	-16.12%
2019 Q4	143.43 Million SEK	26.6%
2018 Q1	85.21 Million SEK	-7.07%
2018 FY	398.82 Million SEK	20.37%
2018 Q2	94.38 Million SEK	10.76%
2018 Q3	96.24 Million SEK	1.98%
2018 Q4	122.98 Million SEK	27.78%
2017 Q3	77.98 Million SEK	-7.0%
2017 Q1	77.8 Million SEK	-12.5%
2017 Q2	83.85 Million SEK	7.77%
2017 FY	331.34 Million SEK	12.77%
2017 Q4	91.69 Million SEK	17.58%
2016 Q4	88.92 Million SEK	28.97%
2016 FY	293.83 Million SEK	8.83%
2016 Q2	68.86 Million SEK	2.64%
2016 Q1	67.09 Million SEK	-12.13%
2016 Q3	68.95 Million SEK	0.12%
2015 FY	269.98 Million SEK	20.34%
2015 Q4	76.35 Million SEK	17.73%
2015 Q3	64.85 Million SEK	-2.83%
2015 Q2	66.74 Million SEK	7.61%
2015 Q1	62.02 Million SEK	-8.72%
2014 FY	224.35 Million SEK	6.64%
2014 Q2	52.11 Million SEK	-0.23%
2014 Q3	52.06 Million SEK	-0.09%
2014 Q1	52.23 Million SEK	-2.25%
2014 Q4	67.94 Million SEK	30.51%
2013 Q3	50.95 Million SEK	-5.27%
2013 FY	210.38 Million SEK	-6.86%
2013 Q1	52.21 Million SEK	-4.37%
2013 Q2	53.79 Million SEK	3.02%
2013 Q4	53.43 Million SEK	4.85%
2012 Q4	54.59 Million SEK	0.76%
2012 Q3	54.18 Million SEK	-5.81%
2012 Q1	59.72 Million SEK	10.49%
2012 Q2	57.53 Million SEK	-3.68%
2012 FY	225.88 Million SEK	2.12%
2011 FY	221.2 Million SEK	-4.06%
2011 Q2	56.13 Million SEK	-7.01%
2011 Q3	50.63 Million SEK	-9.8%
2011 Q4	54.05 Million SEK	6.75%
2011 Q1	60.37 Million SEK	-4.26%
2010 Q3	60.09 Million SEK	13.03%
2010 Q2	53.16 Million SEK	-2.0%
2010 Q1	54.24 Million SEK	7.84%
2010 FY	230.56 Million SEK	-1.98%
2010 Q4	63.05 Million SEK	4.93%
2009 Q2	57.43 Million SEK	0.46%
2009 Q4	50.3 Million SEK	2.34%
2009 Q1	57.17 Million SEK	0.0%
2009 FY	235.22 Million SEK	16.47%
2009 Q3	49.15 Million SEK	-14.42%
2008 FY	201.96 Million SEK	-22.63%
2007 FY	261.02 Million SEK	-13.59%
2006 FY	302.07 Million SEK	5.78%
2005 FY	285.58 Million SEK	2.39%
2004 FY	278.92 Million SEK	10.2%
2003 FY	253.11 Million SEK	10.53%
2002 FY	229 Million SEK	0.0%

Peer Operating Expenses Comparison of Biotage AB (publ)

Name	Operating Expenses	Operating Expenses Difference
AddLife AB (publ)	3.01 Billion SEK	78.865%
Bonesupport Holding AB (publ)	510.93 Million SEK	-24.675%
Doxa AB (publ)	-259.5 Million SEK	345.472%
Elekta AB (publ)	3.39 Billion SEK	81.209%
iZafe Group AB (publ)	35.92 Million SEK	-1672.99%
Ortivus AB (publ)	48.45 Million SEK	-1214.676%
Ortivus AB (publ)	48.45 Million SEK	-1214.676%
Q-linea AB (publ)	-43 Thousand SEK	1481495.349%
S2Medical AB (publ)	20.3 Million SEK	-3037.797%
Synsam AB (publ)	3.76 Billion SEK	83.068%

Global Stocks Search

Biotage AB (publ) (BIOT.ST)

Operating Expenses Summary of Biotage AB (publ)

Annual Operating Expenses Chart of Biotage AB (publ) (2023 - 2002)

Historical Annual Operating Expenses of Biotage AB (publ) (2023 - 2002)

Peer Operating Expenses Comparison of Biotage AB (publ)